Plasma Pen Treatment: Risks, Reality, and Better Options

Plasma Pen Treatment: What It Is, How It Works, and Why We Recommend Better Alternatives

What Is a Plasma Pen?

A plasma pen (also called a fibroblast pen or plasma fibroblast device) is a handheld tool that generates a small electrical arc from ionized gas. When held close to the skin without touching it, the arc causes sublimation: the top layer of skin vaporizes on contact, creating a micro-wound at the surface. The idea is that this controlled injury triggers the skin’s healing response, stimulating fibroblasts (the cells responsible for collagen production) to lay down new tissue.

Proponents market these devices for wrinkles, fine lines, loose eyelid skin, jowl laxity, and general skin tightening on the face and neck. You may also see it sold under the name “soft surgery” or “non-surgical blepharoplasty.” The marketing is compelling. The clinical picture is more complicated.

How Plasma Pens Are Marketed and What the Research Actually Shows

The appeal is understandable: a non-surgical device promising skin tightening results. But the regulatory and evidence record tells a different story.

FDA clearance status: Plasma pen devices are not FDA-cleared for aesthetic facial procedures. In September 2022, the FDA issued a warning letter to a plasma pen manufacturer for selling its devices without the required premarket approval. The company itself acknowledged the devices require regulatory clearance they did not have.

What social media shows: Social media posts promoting fibroblast pens are often based on unsubstantiated claims, are mostly posted by people who are not medical professionals, and describe uses the FDA has not cleared. Despite this, the devices continue to circulate widely in the aesthetics gray market.

There is some evidence that plasma energy can produce collagen-stimulating effects, and this is not disputed. What is disputed is the consistency, predictability, and safety of consumer-grade plasma devices in aesthetic settings. No randomized controlled trial evidence supports the wide range of claims made in marketing.

Risks and Side Effects of Plasma Pen Treatment

Every procedure has a risk profile. Plasma pen’s full risk profile is one of the reasons this device is no longer part of our treatment menu, and we think you deserve to know exactly what it looks like before making any decision.

Common side effects: Redness, swelling, and scabbing are expected. The small dots of sublimated tissue form visible crusts that take 7–14 days to resolve, during which normal social activities may be uncomfortable. This is marketed as “minimal downtime” in many places, though two weeks of visible skin changes is a meaningful interruption for most people.

Thermal burns and permanent scarring: The electrical arc is not perfectly controllable at the consumer device level. Plasma pen burns can need emergency care and can leave scarring and color changes that last for months. This risk is documented in the medical literature.

Post-inflammatory hyperpigmentation (PIH): PIH (darker patches of skin that appear at the treatment site as it heals) can follow plasma procedures. For patients with medium to deeper skin tones (Fitzpatrick III–VI), PIH risk is significantly higher with any thermal procedure that creates surface injury.

Ocular injury risk: For periorbital use, which is among the most commonly marketed applications, numbing cream used before a plasma pen procedure can get into the eyes and cause a chemical eye injury. Proximity to the eye makes this application particularly sensitive.

These risks increase substantially when the procedure is performed by non-licensed practitioners, using at-home consumer devices, or following tutorials on social media.

Why We Don’t Offer Plasma Pens at Desert Bloom

Desert Bloom does not offer plasma pen treatments. This is a deliberate clinical decision, not a gap in our menu.

The thermal injury zone of consumer-grade plasma devices is not predictable enough for consistent clinical results. In a practice committed to outcomes we can stand behind, “variable” is not acceptable, particularly when the alternative treatments we offer produce more reliable tissue responses with better-established safety profiles. For the concerns plasma pens are marketed to address, we have options that we are confident in: RF Microneedling, PDO Thread Lift, CO2 Laser Resurfacing, and Erbium Laser Resurfacing.

What We Offer Instead

RF Microneedling for Skin Tightening and Texture

RF Microneedling delivers radiofrequency energy through a matrix of microneedles directly into the dermis, the deeper structural layer of the skin. This creates a precise thermal response that stimulates collagen and elastin remodeling without the surface unpredictability of plasma sublimation. It is FDA-cleared, effective across all skin types including Fitzpatrick V–VI, and consistently addresses laxity, texture irregularities, pore size, and fine lines. Downtime is typically 2–5 days.

PDO Thread Lift for Laxity and Lifting

When the primary concern is tissue descent (jowls, brow drop, loose neck skin, or midface flattening), PDO Thread Lift addresses the structural cause directly. Absorbable polydioxanone sutures are placed beneath the skin, mechanically repositioning tissue and creating a collagen-stimulating response along the thread tract. The lift is immediate; the gradual tissue response continues for up to six months. For patients exploring plasma pen specifically because they want a “non-surgical lift,” threads are a significantly more direct and predictable solution.

CO2 Laser Resurfacing for Surface Texture and Deeper Wrinkles

CO2 Laser Resurfacing uses an ablative wavelength to remove controlled layers of skin and trigger deep collagen remodeling. It is among the most effective treatments available for wrinkles, sun damage, uneven texture, and eyelid skin laxity, the same concerns frequently cited in plasma pen marketing. The depth of treatment is calibrated precisely. Downtime is 5–7 days for CoolPeel and 10–14 days for deeper resurfacing, depending on intensity: the denser the treatment, the longer the recovery. This is a more involved recovery than plasma pen, but the outcome reliability is substantially better-documented.

Erbium Laser Resurfacing: Moderate Resurfacing with Shorter Recovery

For patients who want surface resurfacing (fine lines, texture, mild laxity, sun damage) with a shorter recovery, Erbium Laser Resurfacing offers a middle path. The Er:YAG wavelength removes tissue with less collateral heat than CO2, which generally means 5–10 days of downtime and a gentler healing curve. It is a strong option for first-time resurfacing patients and for those with moderate skin concerns who are not yet candidates for deeper CO2 resurfacing. Desert Bloom does not offer full ablative CO2, because it requires general anesthesia and a sterile operating room setting and carries a high risk of infection and scarring.

Plasma Pen vs. Our Alternatives, Side by Side